Literature DB >> 29242336

Improving regulation of microbiota transplants.

Diane Hoffmann1, Francis Palumbo2, Jacques Ravel2, Mary-Claire Roghmann2,3, Virginia Rowthorn2, Erik von Rosenvinge2,3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29242336      PMCID： PMC5773100          DOI： 10.1126/science.aaq0034

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  9 in total

1.  Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection.

Authors:  G Cammarota; L Masucci; G Ianiro; S Bibbò; G Dinoi; G Costamagna; M Sanguinetti; A Gasbarrini
Journal:  Aliment Pharmacol Ther       Date:  2015-03-01       Impact factor: 8.171

2.  Ensuring the safe and effective FDA regulation of fecal microbiota transplantation.

Authors:  Rachel E Sachs; Carolyn A Edelstein
Journal:  J Law Biosci       Date:  2015-07-06

3.  Policy: How to regulate faecal transplants.

Authors:  Mark B Smith; Colleen Kelly; Eric J Alm
Journal:  Nature       Date:  2014-02-20       Impact factor: 49.962

Review 4.  From stool transplants to next-generation microbiota therapeutics.

Authors:  Elaine O Petrof; Alexander Khoruts
Journal:  Gastroenterology       Date:  2014-01-08       Impact factor: 22.682

5.  Burden of Clostridium difficile infection in the United States.

Authors:  Fernanda C Lessa; Yi Mu; Wendy M Bamberg; Zintars G Beldavs; Ghinwa K Dumyati; John R Dunn; Monica M Farley; Stacy M Holzbauer; James I Meek; Erin C Phipps; Lucy E Wilson; Lisa G Winston; Jessica A Cohen; Brandi M Limbago; Scott K Fridkin; Dale N Gerding; L Clifford McDonald
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

6.  Duodenal infusion of donor feces for recurrent Clostridium difficile.

Authors:  Els van Nood; Anne Vrieze; Max Nieuwdorp; Susana Fuentes; Erwin G Zoetendal; Willem M de Vos; Caroline E Visser; Ed J Kuijper; Joep F W M Bartelsman; Jan G P Tijssen; Peter Speelman; Marcel G W Dijkgraaf; Josbert J Keller
Journal:  N Engl J Med       Date:  2013-01-16       Impact factor: 91.245

7.  FDA's pathway for regulation of FMT: not so fraught.

Authors:  Margaret F Riley; Bernat Olle
Journal:  J Law Biosci       Date:  2015-10-26

8.  Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.

Authors:  Colleen R Kelly; Alexander Khoruts; Christopher Staley; Michael J Sadowsky; Mortadha Abd; Mustafa Alani; Brianna Bakow; Patrizia Curran; Joyce McKenney; Allison Tisch; Steven E Reinert; Jason T Machan; Lawrence J Brandt
Journal:  Ann Intern Med       Date:  2016-08-23       Impact factor: 25.391

9.  Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.

Authors:  Yang Song; Shashank Garg; Mohit Girotra; Cynthia Maddox; Erik C von Rosenvinge; Anand Dutta; Sudhir Dutta; W Florian Fricke
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240
  9 in total
  13 in total

1.  Antibiotic treatment and stewardship in the era of microbiota-oriented diagnostics.

Authors:  Debby Bogaert; Alex van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-06       Impact factor: 3.267

Review 2.  Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology.

Authors:  Alexander Khoruts; Christopher Staley; Michael J Sadowsky
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-25       Impact factor: 46.802

3.  The Safety of Fecal Microbiota Transplantation for Crohn's Disease: Findings from A Long-Term Study.

Authors:  Honggang Wang; Bota Cui; Qianqian Li; Xiao Ding; Pan Li; Ting Zhang; Xiaozhong Yang; Guozhong Ji; Faming Zhang
Journal:  Adv Ther       Date:  2018-10-16       Impact factor: 3.845

4.  Towards a rational design of faecal transplant analogues.

Authors:  Olaf F A Larsen; Anton H J Koning; Peter J van der Spek; Eric Claassen
Journal:  Sci Rep       Date:  2019-04-03       Impact factor: 4.379

Review 5.  Microbiome Dependent Regulation of Tregs and Th17 Cells in Mucosa.

Authors:  Pushpa Pandiyan; Natarajan Bhaskaran; Mangge Zou; Elizabeth Schneider; Sangeetha Jayaraman; Jochen Huehn
Journal:  Front Immunol       Date:  2019-03-08       Impact factor: 7.561

Review 6.  Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients.

Authors:  H R Wardill; K R Secombe; R V Bryant; M D Hazenberg; S P Costello
Journal:  EBioMedicine       Date:  2019-03-30       Impact factor: 8.143

7.  Banking feces: a new frontier for public blood banks?

Authors:  Simon Mark Dahl Jørgensen; Christian Lodberg Hvas; Jens Frederik Dahlerup; Susan Mikkelsen; Lars Ehlers; Lianna Hede Hammeken; Tine Rask Licht; Martin Iain Bahl; Christian Erikstrup
Journal:  Transfusion       Date:  2019-06-26       Impact factor: 3.157

Review 8.  Microbiota transplantation: concept, methodology and strategy for its modernization.

Authors:  Faming Zhang; Bota Cui; Xingxiang He; Yuqiang Nie; Kaichun Wu; Daiming Fan
Journal:  Protein Cell       Date:  2018-04-24       Impact factor: 14.870

Review 9.  Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics.

Authors:  Chenbo Ding; Wendong Tang; Xiaobo Fan; Guoqiu Wu
Journal:  Onco Targets Ther       Date:  2018-08-13       Impact factor: 4.147

Review 10.  Seven facts and five initiatives for gut microbiome research.

Authors:  Danyi Li; Chunhui Gao; Faming Zhang; Ruifu Yang; Canhui Lan; Yonghui Ma; Jun Wang
Journal:  Protein Cell       Date:  2020-06       Impact factor: 14.870
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.